Red blood cell alloimmunization in transfused patients in sub-Saharan Africa: A systematic review and meta-analysis

Transfusion and Apheresis Science

Volumn 54, Issue 2, 2016, Pages 296-302

  Ngoma, Alain M ^a   Mutombo, Paulin B ^b   Ikeda, Kazuhiko ^c   Nollet, Kenneth E ^c   Natukunda, Bernard ^d   Ohto, Hitoshi ^c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF KINSHASA   (Congo)

^c FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^d MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

Blood transfusion; Haemolytic transfusion reactions; RBC alloantibodies; Sub Saharan Africa

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY; FY A ANTIBODY; FY B ANTIBODY; JK A ANTIBODY; JK B ANTIBODY; JS A ANTIBODY; JS B ANTIBODY; K ANTIBODY; KP A ANTIBODY; KP B ANTIBODY; LE A ANTIBODY; LE B ANTIBODY; LU A ANTIBODY; LU B ANTIBODY; M ANTIBODY; N ANTIBODY; RED BLOOD CELL ALLOANTIBODY; RHESUS C ANTIBODY; RHESUS C W ANTIBODY; RHESUS D ANTIBODY; RHESUS E ANTIBODY; S ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIGEN;

AFRICA SOUTH OF THE SAHARA; ALLOIMMUNIZATION; ANTIBODY SPECIFICITY; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD GROUP RHESUS SYSTEM; BLOOD TRANSFUSION; HUMAN; RED BLOOD CELL ALLOIMMUNIZATION; REVIEW; SYSTEMATIC REVIEW; ADVERSE EFFECTS; BLOOD; BLOOD GROUP INCOMPATIBILITY; ERYTHROCYTE TRANSFUSION; FEMALE; MALE; META ANALYSIS;

AFRICA SOUTH OF THE SAHARA; BLOOD GROUP INCOMPATIBILITY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; ISOANTIBODIES; ISOANTIGENS; MALE;

EID: 84947312765     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2015.10.017     Document Type: Review

References (41)

1. Chou ST, Liem RI, Thompson AA Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012, 159:394-404.
2. Moise KJ Red blood cell alloimmunization in pregnancy. Semin Hematol 2005, 42:169-178.
3. Zalpuri S, Zwaginga JJ, le Cessie S, Elshuis J, Schonewille H, van der Bom JG Red blood cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2012, 102:144-149.
4. Lindenburg IT, Smits-Wintjens VE, van Klink JM, Verduin E, van Kamp IL, Walther FJ, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 2012, 206:141. e1-8.
5. US Food and Drug Administration Center for Biologics Evaluation and Research Fatalities Reported to FDA Following Blood Collection and Transfusion: Annual Summary for Fiscal Year, accessed 06.14. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ReportaProblem/TransfusionDonationFatalities/ucm346639.htm.
6. Population Reference Bureau (PRB) World Population data sheet accessed 12.14. http://www.prb.org/Publications/Datasheets/2013/2013-world-population-data-sheet/data-sheet.aspx.
7. Dzik WS, Delaney M The future of transfusion and Africa. Transfusion 2014, 54:2791-2794.
8. Tapko J-BMP, Diarra-Nama AJ Status of blood safety in the WHO African region: report of the 2006 survey 2006, WHO Regional Office for Africa, Brazzaville, Republic of Congo, accessed 12.14. http://apps.who.int/iris/handle.
9. Bloch EM, Vermeulen M, Murphy E Blood transfusion safety in Africa: a literature review of infectious disease and organizational challenges. Transfus Med Rev 2012, 26:164-180.
10. Lund TC, Hume H, Allain JP, McCullough J, Dzik W The blood supply in Sub-Saharan Africa: needs, challenges, and solutions. Transfus Apher Sci 2013, 49:416-421.
11. Bugge HF, Karlsen NC, Oydna E, Rake MM, Wexels N, Bendabenda J, et al. A study of blood transfusion services at a district hospital in Malawi. Vox Sang 2013, 104:37-45.
12. Osaro E, Charles AT The challenges of meeting the blood transfusion requirements in Sub-Saharan Africa: the need for the development of alternatives to allogenic blood. J Blood Med 2011, 2:7-21.
13. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009, 6:e1000097.
14. Schwarzer G Package 'meta' The R Foundation for Statistical Computing, accessed 12.14. http://cran.r-project.org/web/packages/meta/meta.pdf.
15. Fleiss JL The statistical basis of meta-analysis. Stat Methods Med Res 1993, 2:121-145.
16. Egger M, Smith GD Meta-analysis. Potentials and promise. BMJ 1997, 315:1371-1374.
17. Rucker G, Schwarzer G, Carpenter J, Olkin I Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Stat Med 2009, 28:721-738.
18. Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T Meta-analysis of prevalence. J Epidemiol Community Health 2013, 67:974-978.
19. Higgins JP, Thompson SG Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
20. Egger M, Davey Smith G, Schneider M, Minder C Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
21. Begg CB, Mazumdar M Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
22. Natukunda BM, Schonewille H, Ndugwa C, Brand A Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010, 50:20-25.
23. Natukunda B, Schonewille H, van de Watering L, Brand A Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010, 98:167-171.
24. Diarra AB, Guindo A, Kouriba B, Dorie A, Diabaté DT, Diawara SI, et al. Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients. Transfus Clin Biol 2013, 20:476-481.
25. Baby M, Fongoro S, Cissé M, Gakou Y, Bathily M, Dembélé AK, et al. Frequency of red blood cell alloimmunization in polytransfused patients at the university teaching hospital of Point G, Bamako, Mali. Transfus Clin Biol 2010, 17:218-222.
26. Abbas M, Bolad A, Jiefri N, Mergani A Red blood cell alloimmunization among Sudanese homozygous sickle cell disease patients. Am J Med Sci 2013, 3:61-67.
27. Meda EMP, Marlow T, Reid C, Roberts DJ, Makani J Red blood cell alloimmunization in sickle cell disease patients in Tanzania. East Afr J Public Health 2014, 11:775-780.
28. Aguiah Vianou B Contribution à l'étude de l'Allo immunisation post- transfusionnelle chez les patients transfusés à Cotonou Bénin Thesis; Bénin: Université d'Abomey-Calavi, accessed 12.14. http://www.memoireonline.com/02/13/6974/.
29. Ndahimana E, Gothot A, Gérard C, Senyana F, R'zik S, Mukabayire O, et al. Risk of red blood cell alloimmunisation in Rwanda: assessment of pretransfusion crossmatch techniques used in district hospitals. East Afr Med J 2013, 90:277-282.
30. Mwambungu A, Nathan S Frequency and distribution of RBC alloantibodies among transfused patients at Ndola Central Hospital, Zambia. Int J Sci Res 2014, 3:86-89.
31. Batina Agasa S, Dupont E, Kayembe T, Molima P, Malengela R, Kabemba S, et al. Multiple transfusions for sickle cell disease in the Democratic Republic of Congo: the importance of the hepatitis C virus. Transfus Clin Biol 2010, 17:254-259.
32. Ugwu NI, Awodu OA, Bazuaye GN, Okoye AE Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria. Niger J Clin Pract 2015, 18:522-526.
33. Issitt PD, Anstee DJ Applied blood group serology 1998, 873-875. Montgomery Scientific, Durham (NC). 4th ed.
34. Garratty G Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion 1997, 37:357-361.
35. Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001, 113:661-665.
36. Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013, 53:710-715.
37. Adias TC, Erhabor O Suboptimal testing for alloantibodies in sub Saharan Africa: bane to effective immunohaematological services delivery. Int J Med Sci 2013, 1:13-22.
38. Natukunda B, Brand A, Schonewille H Red blood cell alloimmunization from an African perspective. Curr Opin Hematol 2010, 17:565-570.
39. Reid ME, Lomas-Francis C, Olsson ML The Blood Group Antigen FactsBook 2012, Academic Press. Third ed.
40. Schonewille H, Haak HL, van Zijl AM RBC antibody persistence. Transfusion 2000, 40:1127-1131.
41. Reverberi R The persistence of red cell alloantibodies. Blood Transfus 2008, 6:225-234.